![Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease – Demystifying controversies - ScienceDirect Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease – Demystifying controversies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0019483216303765-gr1.jpg)
Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease – Demystifying controversies - ScienceDirect
![A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-016-0365-x/MediaObjects/12933_2016_365_Fig1_HTML.gif)
A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan
![Frontiers | Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis Frontiers | Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis](https://www.frontiersin.org/files/Articles/638611/fphar-12-638611-HTML-r1/image_m/fphar-12-638611-g002.jpg)
Frontiers | Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis
![Effect of Enalapril on Glomerular Filtration Rate and Proteinuria in Children with Chronic Kidney Disease: A Randomized Controlled Trial Effect of Enalapril on Glomerular Filtration Rate and Proteinuria in Children with Chronic Kidney Disease: A Randomized Controlled Trial](https://www.indianpediatrics.net/oct2013/images/rp2-1.gif)
Effect of Enalapril on Glomerular Filtration Rate and Proteinuria in Children with Chronic Kidney Disease: A Randomized Controlled Trial
![Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? | Hypertension Research Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? | Hypertension Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41440-022-00902-7/MediaObjects/41440_2022_902_Fig1_HTML.png)
Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? | Hypertension Research
![Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study | BMJ Open Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/6/12/e012690/F1.large.jpg)
Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study | BMJ Open
![End stage renal disease free rates stratified by chronic kidney disease... | Download Scientific Diagram End stage renal disease free rates stratified by chronic kidney disease... | Download Scientific Diagram](https://www.researchgate.net/publication/299566682/figure/fig2/AS:348620965597184@1460129123039/End-stage-renal-disease-free-rates-stratified-by-chronic-kidney-disease-or-not-for-ACEi.png)
End stage renal disease free rates stratified by chronic kidney disease... | Download Scientific Diagram
![Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-38991-z/MediaObjects/41598_2019_38991_Fig1_HTML.png)
Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports
![Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study - eClinicalMedicine Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/745187dc-20a9-4d7f-bbd4-12ce6d5deca4/gr1.jpg)
Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study - eClinicalMedicine
![Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease | Drug Safety Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease | Drug Safety](https://media.springernature.com/m685/springer-static/image/art%3A10.2165%2F00002018-200022050-00003/MediaObjects/40264_2012_22050350_Tab2.jpg)
Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease | Drug Safety
![Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease | Drug Safety Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease | Drug Safety](https://media.springernature.com/m685/springer-static/image/art%3A10.2165%2F00002018-200022050-00003/MediaObjects/40264_2012_22050350_Tab1.jpg)
Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease | Drug Safety
![Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review - Journal of Cardiac Failure Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review - Journal of Cardiac Failure](https://onlinejcf.com/cms/attachment/bcf78a73-e021-41e5-9882-198c5024e7a9/gr1.jpg)
Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review - Journal of Cardiac Failure
![Chronic Kidney Disease and RAAS Blockade: A New view of Renoprotection: Late onset renal failure from RAAS blockade (LORFFAB) Syndrome of rapid onset end-stage renal disease (SORO-ESRD) : Onuigbo, Macaulay, Onuigbo, Nnonyelum: Chronic Kidney Disease and RAAS Blockade: A New view of Renoprotection: Late onset renal failure from RAAS blockade (LORFFAB) Syndrome of rapid onset end-stage renal disease (SORO-ESRD) : Onuigbo, Macaulay, Onuigbo, Nnonyelum:](https://m.media-amazon.com/images/I/61aldC0odrL._AC_UF894,1000_QL80_.jpg)
Chronic Kidney Disease and RAAS Blockade: A New view of Renoprotection: Late onset renal failure from RAAS blockade (LORFFAB) Syndrome of rapid onset end-stage renal disease (SORO-ESRD) : Onuigbo, Macaulay, Onuigbo, Nnonyelum:
![Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis - The Lancet Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis - The Lancet](https://www.thelancet.com/cms/attachment/a5f71584-c7ac-46bd-bdf6-eea5377ee1bb/gr1.gif)
Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis - The Lancet
![Overall end stage renal disease free rates for ACEi and ARB users after... | Download Scientific Diagram Overall end stage renal disease free rates for ACEi and ARB users after... | Download Scientific Diagram](https://www.researchgate.net/publication/299566682/figure/fig4/AS:962850986156033@1606572972341/Overall-end-stage-renal-disease-free-rates-for-ACEi-and-ARB-users-after-propensity-score.gif)
Overall end stage renal disease free rates for ACEi and ARB users after... | Download Scientific Diagram
![ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/86/9/601/F1.large.jpg)
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
![ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death - ScienceDirect ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2590059520300340-gr1.jpg)